|
|
|
|
LEADER |
00000cam a2200000Mu 4500 |
001 |
EBSCO_on1130903383 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr |n|---||||| |
008 |
200321s2019 si o 000 0 eng d |
040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d OCLCQ
|d UKAHL
|d OCLCQ
|d N$T
|d OCLCO
|d OCLCF
|d K6U
|d OCLCO
|d OCLCQ
|d OCLCO
|
020 |
|
|
|a 9811432732
|
020 |
|
|
|a 9789811432736
|q (electronic bk.)
|
035 |
|
|
|a (OCoLC)1130903383
|
050 |
|
4 |
|a RM267
|
082 |
0 |
4 |
|a 615.3/29
|2 23
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Current Perspectives on Anti-Infective Agents.
|
260 |
|
|
|a Singapore :
|b Bentham Science Publishers,
|c 2019.
|
300 |
|
|
|a 1 online resource (278 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Frontiers in Anti-Infective Agents ;
|v volume 1
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- List of Contributors -- Prospects of Actinobacteria from Underexplored Ecosystems as Anti-infective Agents against Mycobacterium tuberculosis -- K. Tamreihao1,2,*, Saikat Mukherjee1, Debananda S. Ningthoujam1 and Subhra Saikat Roy2 -- INTRODUCTION -- Infection and Evolution of Drug-Resistance by M. tuberculosis -- Perspective of Actinobacteria as Anti-TB Agents -- Need for Exploration of Actinobacteria from Unexplored/Under-Explored Ecosystem
|
505 |
8 |
|
|a Antimycobacterial Agents from Actinobacteria Associated with Medicinal Plants -- Antimycobacterial Agents from Actinobacteria from Other Under-Explored Ecosystems -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Protozoan and Helminth Infections: Epidemiology and Anti Infective Therapy -- Saikat Mukherjee1,*, K. Tamreihao1, Rakhi Khunjamayum1, Khullakpam Shaheen1, Elangbam Shanta Singh1, Debananda S. Ningthoujam1 and Sumita Banerjee2 -- PROTOZOAN INFECTIONS: EPIDEMIOLOGY AND ANTI-PROTOZOAN DRUGS (SPECIAL EMPHASIS ON LEISHMANIASIS)
|
505 |
8 |
|
|a Introduction -- Leishmaniasis -- General Description -- Vectors for Leishmaniasis -- Life Cycle of Leishmania -- Life Cycle in the Sand Fly -- Life Cycle in the Vertebrate -- Morphology of Leishmania -- Morphological and Molecular Changes during Transformation of Leishmania sp. -- Transformation from Amastigote to Promastigote -- Transformation from Promastigote to Amastigote Form -- Pathogenesis and Inflammation of Leishmania -- Various Anti Leishmania Drugs Available/ Clinical Trials (Table 1) -- Pentavalent Antimonials -- Miltefosine -- Pentamidine -- Paromomycin -- Amphotericin B
|
505 |
8 |
|
|a Sitamaquine -- 8-aminoquinolines -- 2-substituted Quinolines -- Buparvaquone -- Combination Chemotherapy -- CONCLUDING REMARKS -- HELMINTH INFECTIONS: EPIDEMIOLOGY AND ANTI-HELMINTHIC DRUGS (SPECIAL EMPHASIS ON ELEPHANTIASIS) -- Introduction -- Elephantiasis -- Filarial Elephantiasis -- Podoconiosis (Non Filarial Elephantiasis) -- Anti-Elephantiasis Drugs -- CONCLUDING REMARKS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Therapeutic Drugs Used for Effective Lifelong Control of HIV and AIDS
|
505 |
8 |
|
|a Elangbam Shanta Singh1,*, Debananda S. Ningthoujam1, Laishram Jaya Devi1, Rakhi Khunjamayum1, Dollyca Ningombam2 and Laishram Somenkumar Singh3 -- INTRODUCTION -- Types of HIV -- Brief History of HIV and AIDS -- Structure of HIV -- HIV Genome and Functions of Genes -- Structural Genes -- gag (Group Specific Antigen) Gene -- pol (Polymerase) Gene -- env (Envelop Protein) Gene -- Regulatory Genes -- tat (Transcriptional Transactivator) Gene -- rev Gene -- Accessory Genes -- Life Cycle and Mechanisms of HIV Infection -- Routes of HIV Transmission -- Stages of HIV Infections and Symptoms
|
500 |
|
|
|a First Stage: Acute HIV Infection
|
520 |
|
|
|a The volume is a comprehensive documentation on major infectious diseases from tropical countries which pose a serious threat to global healthcare programs. These include diseases such as tuberculosis, AIDS, leishmaniasis (kala-azar), elephantiasis, malaria, leprosy, various fungal disorders and emergent viral diseases. Due to the widespread use of antibiotics, there is an emergence of drug resistant pathogens in many regions. Hence, there is a need to search for novel, cost-effective bioactive compounds that demonstrate high efficacy and low toxicity in human cells from unexplored ecosystems t.
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Anti-infective agents.
|
650 |
|
2 |
|a Anti-Infective Agents
|
650 |
|
6 |
|a Antiinfectieux.
|
650 |
|
7 |
|a Anti-infective agents
|2 fast
|
700 |
1 |
|
|a Tamreihao, K.
|
700 |
1 |
|
|a Mukherjee, Saikat.
|
700 |
1 |
|
|a Niṃthaujama, Debānanda Esa.,
|d 1961-
|
776 |
0 |
8 |
|i Print version:
|a Tamreihao, K.
|t Current Perspectives on Anti-Infective Agents.
|d Singapore : Bentham Science Publishers, ©2019
|z 9789811432729
|
830 |
|
0 |
|a Frontiers in Anti-Infective Agents ;
|v volume 1.
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2325305
|z Texto completo
|
938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH37369258
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL5990766
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 2325305
|
994 |
|
|
|a 92
|b IZTAP
|